CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis

作者: Marco Scarpa , Paola Brun , Melania Scarpa , Susan Morgan , Andrea Porzionato

DOI: 10.18632/ONCOTARGET.2780

关键词:

摘要: In patients with ulcerative colitis (UC) the cumulative risk of colon cancer is lower than actual rate dysplasia suggesting an efficient immune surveillance mechanism. Since co-stimulatory molecule CD80 overexpressed in dysplastic colonic mucosa UC and T-cell activation entails effective costimulation, we aimed to evaluate functional implication signaling UC-associated carcinogenesis. humans, observed that percentage CD80+ HLA-A+ IEC was increased patients. vitro, activated CD8+ T-cells through a CD80-dependent pathway. Finally, AOM/DSS-induced adenocarcinoma model inhibition significantly frequency extension high-grade dysplasia, whereas enhancing activity anti-CTLA4 antibody decreased dysplasia. conclusion, between represents key factor controlling progression from low high grade inflammatory

参考文章(44)
F. M. Burnet, The concept of immunological surveillance. Progress in Experimental Tumor Research. ,vol. 13, pp. 1- 27 ,(1970) , 10.1159/000386035
Jeffrey Schlom, Judy A. Kantor, James W. Hodge, Scott Abrams, Induction of Antitumor Immunity by Recombinant Vaccinia Viruses Expressing B7-1 or B7-2 Costimulatory Molecules Cancer Research. ,vol. 54, pp. 5552- 5555 ,(1994)
Annalucia Serafino, Noemi Moroni, Manuela Zonfrillo, Federica Andreola, Luana Mercuri, Giuseppe Nicotera, Joseph Nunziata, Riccardo Ricci, Armando Antinori, Guido Rasi, Pasquale Pierimarchi, WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer. Oncotarget. ,vol. 5, pp. 978- 992 ,(2014) , 10.18632/ONCOTARGET.1571
Marco Scarpa, Roubik Behboo, Imerio Angriman, Attilio Cecchetto, Renata D’Incà, Barbara Termini, Michela Barollo, Cesare Ruffolo, Lino Polese, Giacomo Carlo Sturniolo, Davide Francesco D’Amico, None, Expression of costimulatory molecule CD80 in colonic dysplasia in ulcerative colitis: an immunosurveillance mechanism against colorectal cancer? International Journal of Colorectal Disease. ,vol. 21, pp. 776- 783 ,(2006) , 10.1007/S00384-006-0095-8
Toshiaki Watanabe, Takashi Kobunai, Yoko Yamamoto, Hiroki Ikeuchi, Keiji Matsuda, Soichiro Ishihara, Keijiro Nozawa, Hisae Iinuma, Takamitsu Kanazawa, Toshiaki Tanaka, Tadashi Yokoyama, Tsuyoshi Konishi, Kiyoshi Eshima, Yohichi Ajioka, Toshifumi Hibi, Mamoru Watanabe, Tetsuichiro Muto, Hirokazu Nagawa, Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis. Clinical Colorectal Cancer. ,vol. 10, pp. 134- 141 ,(2011) , 10.1016/J.CLCC.2011.03.011
Lieping Chen, Stephanie Ashe, William A. Brady, Ingegerd Hellström, Karl Erik Hellström, Jeffrey A. Ledbetter, Patrick McGowan, Peter S. Linsley, Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 Cell. ,vol. 71, pp. 1093- 1102 ,(1992) , 10.1016/S0092-8674(05)80059-5
Moritz Koch, Philipp Beckhove, Jan op den Winkel, Daniel Autenrieth, Philipp Wagner, Daniel Nummer, Sebastian Specht, Dalibor Antolovic, Luis Galindo, Friedrich H Schmitz-Winnenthal, Volker Schirrmacher, Markus W Büchler, Jürgen Weitz, None, Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Annals of Surgery. ,vol. 244, pp. 986- 993 ,(2006) , 10.1097/01.SLA.0000247058.43243.7B
Timothy L. Zisman, Mary P. Bronner, Stephen Rulyak, Kris V. Kowdley, Michael Saunders, Scott D. Lee, Cynthia Ko, Michael B. Kimmey, Allyn Stevens, Josephine Maurer, Teresa A. Brentnall, Prospective Study of the Progression of Low-Grade Dysplasia in Ulcerative Colitis Using Current Cancer Surveillance Guidelines Inflammatory Bowel Diseases. ,vol. 18, pp. 2240- 2246 ,(2012) , 10.1002/IBD.22912
Charles A. Janeway, Kim Bottomly, Signals and signs for lymphocyte responses. Cell. ,vol. 76, pp. 275- 285 ,(1994) , 10.1016/0092-8674(94)90335-2